Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.

NEW ORLEANS, LA—Complete revascularization in patients presenting with ACS and multivessel coronary artery disease significantly cuts the risk of cardiovascular mortality and new MI when compared with ...

In patients with ST-elevation myocardial infarction (STEMI) and multivessel disease, fractional flow reserve (FFR)-guided complete nonculprit revascularization did not reduce death, myocardial ...

Study reveals diminished quality of life among patients with chronic limb-threatening ischemia, a severe form of peripheral artery disease, and emphasizes the benefits of revascularization on ...

WASHINGTON, DC—In patients with chronic limb-threatening ischemia (CLTI), delays longer than 30 days from the time of diagnosis to initiation of endovascular revascularization are associated with an ...

For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization ...

Transmyocardial revascularization is a procedure that uses lasers to improve blood flow in the arteries that feed the heart. It may help people who have severe forms of coronary artery disease.

Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization to ...

The AHA's scientific statement on coronary artery revascularization in older adults proposes an individualized, patient-centered approach that accounts for age-related physiologic changes and ...